A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza | NCT01053533 | Trialant
Unknown statusInterventionalNot ApplicableUpdated Jun 8, 2010
A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
ClinicalTrials.gov ID
NCT01053533
Lead Sponsor
Beijing Ditan HospitalOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Not Applicable
Enrollment
1,100Estimated
Last Update Posted
Jun 8, 2010Estimated
Start Date
Jan 2010
Primary Completion Date
Apr 2010Estimated
Completion Date
Apr 2010Estimated
Brief Summary
The aim of this study is to evaluate the effectiveness and safety of Chinese herbal medicines for severe pandemic H1N1 influenza.
Influenza A Virus, H1N1 Subtype
Chinese herbal medicines plus western therapy
western therapy
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of severe pandemic H1N1 influenza patients and pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza
Rapid Diagnostic Tests:positive
Age≥6 years
Influenza symptoms occurred less than 48 hours and body temperature≥37.5℃ for pandemic H1N1 influenza patients with risk factors for severe H1N1 influenza
Exclusion Criteria:
Suffering from mental illness
Attending other clinical studies on influenza
Critical pandemic H1N1 influenza patients
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
Mao YuRecruiting
Beijing, Beijing Municipality 100015, China
Yu MaoContact
myqmz58@yahoo.com
Guang Yu WangContact
influenzatcm@163.com
Guang YU WangPrincipal Investigator
Lead Sponsor
Beijing Ditan HospitalOTHER
Collaborators
Beijing University of Chinese MedicineOTHER
State Administration of Traditional Chinese Medicine of the People's Republic of ChinaOTHER_GOV